Work

Efficacy and Safety of Tislelizumab Versus Pembrolizumab with Chemotherapy as First-Line Treatment for Advanced Squamous Non-Small-Cell Lung Cancer

Year: 2024

Type: preprint

Study design: Observational Study

Source: SSRN Electronic Journal

DOI: 10.2139/ssrn.5010992

Authors: Yu-Fei Zhu, Zhi-Hao Huang, Yun-Yun Zeng, Hui-Yi Huang, Jun Dong, Shan Su

Institutions: Guangzhou Medical University, Guangzhou Chest Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4404470738

Cites:

Cited by:

Related to: 10